Incidence and Kinetics Of Full Donor Chimerism and The Impact Of Minimal Residual Disease Status Follo Outpatient Non-Myeloablative Allogeneic Stem Cell Transplantation For Myeloma

被引：0
|
作者：
Campbell, Philip
Das, Tongted
Kipp, David
Walker, Patricia A.
Muirhead, Jenny
Avery, Sharon
Patil, Sushrut S.
Curtis, David J.
Schwarer, Anthony P.
Kalff, Anna
Spencer, Andrew
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2129.2129
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2129
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Kinetics of engraftment post non-myeloablative stem cell transplantation (full donor chimerism).
    Pugatsch, T
    Aker, M
    Shapira, M
    Slavin, S
    Or, R
    BLOOD, 2000, 96 (11) : 172A - 172A
  • [2] Molecular monitoring of chimerism and minimal residual disease in multiple myeloma patients after non-myeloablative stem cell transplantation
    Galimberti, S
    Benedetti, E
    Fazzi, R
    Papineschi, F
    Caracciolo, F
    Orciuolo, E
    Andreazzoli, F
    Morabito, F
    Cuzzola, M
    Martino, M
    Iacopino, P
    Petrini, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S112 - S112
  • [3] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    P Campbell
    P Walker
    S Avery
    S Patil
    D Curtis
    A Schwarer
    A Wei
    A Kalff
    J Muirhead
    A Spencer
    Blood Cancer Journal, 2014, 4 : e213 - e213
  • [4] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    Campbell, P.
    Walker, P.
    Avery, S.
    Patil, S.
    Curtis, D.
    Schwarer, A.
    Wei, A.
    Kalff, A.
    Muirhead, J.
    Spencer, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e213 - e213
  • [5] Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation
    Junghanss, C
    Storb, R
    Maris, MB
    Carter, RA
    Sandmaier, BM
    Maloney, DG
    McSweeney, PA
    Corey, L
    Boeckh, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (04) : 662 - 670
  • [6] Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation.
    Iannone, R
    Luznik, L
    Engstrom, LW
    Fuchs, EJ
    BLOOD, 1999, 94 (10) : 320B - 321B
  • [7] Kinetics of engrafting donor cells after non-myeloablative allogeneic stem cell transplantation
    Carella, AM
    Corsetti, MT
    Beltrami, G
    Greco, MM
    Scalzulli, PR
    Carella, AM
    BONE MARROW TRANSPLANTATION, 2003, 31 : S149 - S149
  • [8] Non-myeloablative allogeneic hematopoietic stem cell transplantation:: impact of pretransplant factors and chimerism status on transplant outcome with or without donor lymphocyte infusions
    Nicolini, F
    Audigier-Valette, C
    Michallet, A
    Lé, Q
    Boiron, J
    Comeau, F
    Perreau, V
    Sirvent, A
    Bernard, G
    Thiébaut, A
    Vigouroux, C
    Eliaou, J
    Gebuhrer, L
    Dubois, V
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S153 - S153
  • [9] Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
    Galimberti, S
    Benedetti, E
    Morabito, F
    Papineschi, F
    Callea, V
    Fazzi, R
    Stelitano, C
    Andreazzoli, F
    Guerrini, F
    Ciabatti, E
    Martino, M
    Nobile, F
    Iacopino, P
    Petrini, M
    LEUKEMIA RESEARCH, 2005, 29 (08) : 961 - 966
  • [10] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic haematopoietic stem cell transplantation
    Plesa, A.
    Le, Q.
    Revesz, D.
    Thomas, X.
    Ducastelle, S.
    Nicolini, F. E.
    Michallet, A. S.
    Mollet, I.
    Dubois, V.
    Clark, M.
    Dumontet, C.
    Raus, N.
    Sobh, M.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S336 - S336
12345